Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06564896

Comparative Assessment of Sleep Positive Airway Pressure Modalities (CASPAM)

Obstructive sleep apnea (OSA) has been one of the topmost global health problems. It is an underdiagnosed disease which have a huge burden on healthcare if left untreated. Almost 80-90% of adults are underdiagnosed of OSA Obesity primarily is one of the supreme risk factors for developing OSA. Globally, obesity cases have risen affecting almost two billion people. According to National Health and Morbidity Survey (NHMS) 2019, 1 in 2 adults in Malaysia were overweight or obese. Report from World Obesity Atlas 2023 predicts that adult obesity will rise 4.7% annually from 2020 - 2035, while child obesity will increase by 5.3% per year over similar timeline. Overweight individuals will have a significant economic impact on Malaysia's Gross Domestic Product (GDP) by 2035 by 2.8% which is estimated to be about RM 3.2 trillion.

Sequalae of OSA is divided into two (cardiovascular-metabolic effect and neurocognitive effect). This group of patients are at high risk of developing hypertension, insulin resistance, dyslipidemia which then leads to pulmonary hypertension and heart failure. More importantly, from the neurocognitive point of view, persistent sleep deprivation will lead to poor concentration, impaired memory, personality changes affecting overall self-performance which can lead to depression and compromising safety as they have higher risk of work-related accidents.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

National University of Malaysia, Faculty of Medicine

Cheras, Kuala Lumpur, 56000, Malaysia

Location status: Recruiting

Location contact

Mohamed Faisal Abdul Hamid

CONTACT

[email protected]

0391455555

About this study

Hypothesis

  • Participants' overall satisfaction is better using Air-Mini CPAP compared to Airsense CPAP machine.
  • There is no difference in terms of AHI reduction and average 95th centile pressure required between AirMini CPAP compared to Airsense CPAP machine.
  • There will be positive correlation between overall satisfaction and AHI reduction for Air-Mini CPAP compared to Airsense CPAP machine.
  • There is improvement in air leak, comfort, compactness and maintenance in AirMini CPAP machine compared to AirSense CPAP.

This is a prospective cross over trial study of group of patients with moderate to severe OSA based on the severity of the AHI.

This study will be conducted for all moderate to severe OSA participants in Hospital Canselor Tuanku Muhriz (medical and non-medical department) between September 2024 to December 2026.

This is a cross over trial that includes patients with medium to high risk of OSA according to STOPBANG score. Once these group of participants are selected, consent will be taken from them to go through a scheduled sleep study. Diagnosis is established after AHI score is concluded from the polysomnographic study. Those who are diagnosed with moderate to high AHI score will be recruited in this study. All subjects will be given a CPAP trial using both AirSense and AirMini model for 7 days each device. Upon recruitment, the subject will be randomised using 1:1 block randomisation either to receive AIrsense 10 CPAP machine or Air-mini CPAP machine.

Those participants that use AirSense CPAP machine first for 7 days will be given a set of Questionnaire at the end of 7th day of the trial. Subsequently, they will be switch to use Air-Mini CPAP machine for another 7 days and the same set Questionnaire will be given on the 7th day of the trial. The type of the interface used will be based on subject's preferences, i.e., full face mask / nasal masak / nasal pillow, during the initial 1 - 2 days of CPAP trial. The same interface as per subject's preferences will be used throughout the CPAP trials for both AirSense as well as Airmini CPAP machine.

The Questionnaire given comprises of a 100mm Visual Analogue Score (VAS) for: 1) Overall satisfaction, 2) Air Leak, 3) Comfort, 4) Compactness & Portability, 5) Maintenance & Configuration.

The data collected will be analyzed using SPSS Version 27.

This is a cross-sectional prospective study; hence the sample size calculation will be based on Machin et al. (2018) The sample size decided for this study was 40 subjects. Considering and taking into account of about 10% dropout / missing data, hence the total sample size that will be recruited for this study are 50 subjects.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged ≥ 18 years.
  • Patients diagnosed with moderate to severe OSA (based on AHI classification from sleep study performed).
  • Patients who are able to understand and answer the questionnaire given.

Exclusion criteria

  • Patients who are unable to give consent to the study.
  • Patients who have been diagnosed with OSA and already on CPAP machine.
  • Patients who had underlying Obesity Hypoventilation Syndrome (OHS).
  • Patients who had underlying co-morbidities that worsen apnea symptoms, such as congestive cardiac failure, active malignancy, narcolepsy, active alcohol or drug abuse, treatment-refractory dementia, psychotic illness and active use of drugs that disturb the sleep architecture (i.e hypnotics or stimulants of central nervous system).

Treatment and study plan

CPAP Airsense 10 vs Air-Mini

Device

Patients' satisfaction and CPAP efficacy

Primary outcomes

  1. To compare the overall satisfaction using Visual Analogue Score 100mm among moderate to severe OSA participants receiving conventional CPAP Airsense 10 (0 mm - Not Satisfied at all, 100mm - Very Satisfied)

    Time frame: 7 days after first usage of CPAP Airsense 10

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Airsence 10

  2. To compare the overall satisfaction using Visual Analogue Score 100mm among moderate to severe OSA participants receiving CPAP Air-Mini. (0 mm - Not Satisfied at all, 100mm - Very Satisfied)

    Time frame: 7 days after first usage of CPAP Air-Mini

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Air Mini

Secondary outcomes

  1. To evaluate the efficacy of CPAP machine Airsense 10 in terms of percentage AHI reduction (Optimal titration=AHI <5, Good titration=AHI ≤10 or by 50%, Adequate titration= AHI reduction by 75% from baseline)

    Time frame: 7 days after first usage of CPAP Airsense 10

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Airsense 10

  2. To evaluate the efficacy of CPAP machine Air-Mini 10 in terms of percentage AHI reduction (Optimal titration=AHI <5, Good titration=AHI ≤10 or by 50%, Adequate titration= AHI reduction by 75% from baseline)

    Time frame: 7 days after first usage of CPAP Air-Mini

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Air-Mini

  3. To determine the average 95th centile pressure required using conventional CPAP Airsense 10

    Time frame: 7 days after first usage of CPAP Airsence 10

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Airsence 10

  4. To determine the average 95th centile pressure required using CPAP Air-Mini

    Time frame: 7 days after first usage of CPAP Air-Mini

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Air-Mini

  5. To compare the satisfaction using Visual Analogue Score 100mm among moderate to severe OSA participants receiving conventional CPAP Airsense 10 (0 mm - Not Satisfied at all, 100mm - Very Satisfied), in terms of air leak

    Time frame: 7 days after first usage of CPAP Airsence 10

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Airsence 10

  6. To compare the satisfaction using Visual Analogue Score 100mm among moderate to severe OSA participants receiving CPAP Air Mini (0 mm - Not Satisfied at all, 100mm - Very Satisfied), in terms of air leak

    Time frame: 7 days after first usage of CPAP Air-Mini

    Participants with moderate to severe OSA who underwent CPAP trial using Air-Mini

  7. To compare the satisfaction using Visual Analogue Score 100mm among moderate to severe OSA participants receiving CPAP Airsense 10 (0 mm - Not Satisfied at all, 100mm - Very Satisfied), in terms of comfort

    Time frame: 7 days after first usage of CPAP Airsence 10

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Airsence 10

  8. To compare the satisfaction using Visual Analogue Score 100mm among moderate to severe OSA participants receiving CPAP Air-Mini (0 mm - Not Satisfied at all, 100mm - Very Satisfied), in terms of comfort

    Time frame: 7 days after first usage of CPAP Air-Mini

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Air-Mini

  9. To compare the satisfaction using Visual Analogue Score 100mm among moderate to severe OSA participants receiving CPAP Airsense 10 (0 mm - Not Satisfied at all, 100mm - Very Satisfied), in terms of compactness & portability

    Time frame: 7 days after first usage of CPAP Airsence 10

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Airsence 10

  10. To compare the satisfaction using Visual Analogue Score 100mm among moderate to severe OSA participants receiving CPAP Air-Mini (0 mm - Not Satisfied at all, 100mm - Very Satisfied), in terms of compactness & portability

    Time frame: 7 days after first usage of CPAP Air-Mini

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Air-Mini

  11. To compare the satisfaction using Visual Analogue Score 100mm among moderate to severe OSA participants receiving CPAP Airsense 10 (0 mm - Not Satisfied at all, 100mm - Very Satisfied), in terms of maintenance & configuration

    Time frame: 7 days after first usage of CPAP Airsence 10

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Airsence 10

  12. To compare the satisfaction using Visual Analogue Score 100mm among moderate to severe OSA participants receiving CPAP Air-Mini (0 mm - Not Satisfied at all, 100mm - Very Satisfied), in terms of maintenance & configuration

    Time frame: 7 days after first usage of CPAP Air-Mini

    Participants with moderate to severe OSA who underwent CPAP trial using CPAP Air-Mini

Study contacts

Contact information is provided by the study sponsor or research team.

Mohamed Faisal Abdul Hamid, MBBS(IIUM)

CONTACT

[email protected]

0391455555

Sponsors and collaborators

Lead sponsor

National University of Malaysia

Other

Registry information

Official study title

Comparative Assessment of Sleep Positive Airway Pressure Modalities (CASPAM) Trial: Conventional CPAP (AirSense 10) Versus Portable CPAP (AirMini) in Patients With Obstructive Sleep Apnea-A Randomized Crossover Study of User Preference

Acronym: CASPAM

Important dates

Study start
2024
Primary completion
2026
Study completion
2027
First posted
Aug 21, 2024
Registry last updated
Jul 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.